Across TCGA pan-cancer cohorts, LINC02832 RNA differs between tumor and matched normal tissue in 9 of 18 cancer types tested, making tumor–normal expression one of LINC02832’s most consistent transcriptional readouts.
The strongest signal is observed in colon adenocarcinoma (COAD), where LINC02832 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC02832 is over-expressed in tumor, although a few such as BRCA and KICH show the opposite, repressed pattern.
COAD, HNSC, and BRCA are the cancer types where LINC02832 tumor–normal differential expression is most reproducible.
RNA tumor vs normal associations by lineage
Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC02832 RNA (log2); positive values indicate higher expression in tumor. p-values are from the differential-expression test.